Outcomes of ketogenic diet in drug resistant epilepsy

Outcomes of drug resistant epileptic pediatric Patient by modified atkins diet

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511595007508

Enrollment

Registered

2025-11-24

Start date

2025-12-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases Nutritional, Metabolic, Endocrine

Interventions

Modified Atkins Diet.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Children aged 1–18 years. - Diagnosed with drug-resistant epilepsy according to ILAE definition.[2] - On KD for at least 6 months.

Exclusion criteria

Exclusion criteria: - Patients with contraindicated metabolic/genetic conditions. - Non-compliance with KD . - Patients on alternative dietary therapies (e.g., low glycemic diet).

Design outcomes

Primary

Measure	Time frame
1-Control of seizures (frequency and duration) - 2-Quality of life By pediatric Quality of life Inventory (PedsQL 4.0) 3-Cognitive function by stanford binet intelligence scale. 4-Growth parameters (weight, hight and BMI)	—

Secondary

Measure	Time frame
to detect clinical predictors of seizures control in patients with drug resistant epilepsy using MAD.	—

Countries

Egypt

Contacts

Public ContactMahmoud Saber Elsayed

Resident in faculty of medicine sohag university

Mm.ss.elsayed277@gmail.com00201069770585

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026